Posted in | News

CEMEX to Supply Ready-Mix Concrete for Phase 1 of Metro Purple Line Extension in LA

CEMEX, S.A.B. de C.V. announced today that CEMEX USA is participating in Phase 1 of the Metro Purple Line Extension in Los Angeles, California.

This long-awaited extension will improve the Los Angeles public transportation system by linking the west part of the city to the region’s growing rail network. For this project, CEMEX is expected to supply at least 330,000 cubic yards of ready-mix concrete.

Phase 1 will provide high-speed, reliable transportation between popular areas of the city. Expected to be completed in 2023, the extension will comprise a 3.9-mile section of twin-rail subway, plus three underground stations in Los Angeles and Beverly Hills.

Project planning began in 2007 to ensure the completed development of this comprehensive project with the least possible impact on area residents. CEMEX was chosen for this project thanks to the expertise it demonstrated 10 years ago on the LA Metro Gold Line expansion.

"This project will improve transportation and mobility for generations of Los Angeles residents, and CEMEX enjoys the resources and experience to help make it a reality. We are proud to play an important role in building a better future for one of the USA’s greatest cities through the extension of the Metro Purple Line,” said Ignacio Madridejos, President CEMEX USA.

CEMEX is a global building materials company that provides high quality products and reliable service to customers and communities in more than 50 countries. Celebrating its 110th anniversary, CEMEX has a rich history of improving the well-being of those it serves through innovative building solutions, efficiency advancements, and efforts to promote a sustainable future.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.